Michael Terry

Feb 17, 2017

Biocept has appointed Michael Terry to the newly created position of senior vice president of commercial operations, where he will lead the company's commercial organization and oversee its business development initiatives. Prior to joining Biocept, Terry served as executive vice president of commercial operations and corporate development at liquid biopsy firm Trovagene. He has also served as executive vice president of Sequenom as CEO of neonatal diagnostics startup Ligand Dx, and has worked for Lumenis, GE Healthcare, and Aspect Medical Systems, among others.

Michael Terry

Judge Denies Qiagen's Motion to Dismiss Zymo Research's Antitrust Suit

Pediatric Brain Cancer Study Yields Prognostic Clues Tied to T-Cell Receptor Features

InformedDNA Acquires Coriell Life Sciences, Adds PGx Capabilities

Telesis Bio to Raise up to $21M Through Private Stock Placement

AccuStem Sciences Acquires Lung Cancer Screening Test From Italian University Researchers